Abstract:OBJECTIVE:To explore the circadian blood pressure (BP) profile and its influencing factors in essential hypertensive patients after treatment. METHODS:Cross-sectional surveillance was carried out in essential hypertensive subjects after treatment whose clinic blood pressure had been under control as 140/90 mm Hg (1 mm Hg = 0.133 kPa) for at least one month. All patients underwent a twenty-four-hour ambulatory blood pressure monitoring device (spacelabs 90207). The nocturnal fall of blood pressure (BP) was calculated from (daytime mean BP-night-time mean BP)/daytime BP, while 'daytime' values were recorded between 6 h and 22 h and 'night-time' values between 22 h and 6 h. Non-dippers were defined as those whose nocturnal decrease in mean systolic BP and/or mean diastolic BP was < 10% of the daytime BP. Binary logistic regression analysis was used to evaluate the correlation between circadian blood pressure profile and factors as gender, age, height, body mass index (BMI), family history of premature cardiovascular disease, women under age 65 or men under age 55, smoking habits, grade of hypertension, and strategy of antihypertensive drugs. RESULTS:208 treated essential hypertensive patients were enrolled in the study. 79 individuals were dippers and 129 were non-dippers. Data from logistic regression analysis showed that four factors as age, premature family history of cardiovascular disease, overweight or obesity, and strategy of antihypertensive drugs were significantly influencing the circadian blood pressure profile in treated hypertensive patients. The incidence of non-dippers in patients of 70 years of age or older and those between 60 and 69 were 3.3 and 2.3 times of those with less than 60 (P = 0.009 and 0.031, respectively). The prevalence of non-dippers in patients with a premature family history of cardiovascular disease was 3.7 times greater than those in subjects without a premature history of cardiovascular disease (P = 0.029). Similarly, the incidence of non-dippers in patients of overweight (24 = BMI < 28) and obesity (BMI >/= 28) were 3.0 and 4.8 times of those in subjects of normal weight (P = 0.003 and 0.009, respectively). Compared with patients treated with long-acting calcium channel blockers (CCBs), patients treated with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) alone had less prevalence of nondippers (OR = 0.139, P = 0.010). Patients treated with joint antihypertensive scheme including ACE inhibitors or ARBs(but not including diuretics) had the tendency of lower incidence of abnormal circadian blood pressure rhythm (OR = 0.453, P = 0.118). Patients treated with joint antihypertensive scheme including diuretics (not including ACE inhibitors or ARBs) and with joint antihypertensive strategy including diuretics and ACE inhibitors or ARBs had lower incidence of nondippers (OR = 0.378 and 0.273, respectively; P = 0.030 and 0.011, respectively). CONCLUSIONS:Approximately 2/3 treated essential hypertensive patients had a non-dipper blood pressure profile. Age, premature family history of cardiovascular disease, overweight/obesity, and antihypertensive drugs strategy were correlated with circadian blood pressure profile. Compared with long-acting CCBs, diuretics, ACE inhibitors or ARBs might be helpful in keeping the circadian blood pressure rhythm at normal range.

Study on methodology of calculating trough to peak ratio according to ambulatory blood pressure monitoring

Evaluation of irbsartan and indapamide sustained release by different methods of trough/peak ratio and smoothness index calculated in the treatment of hypertention

Blood Pressure Measurement Multicentre Trial

Analysis of trough:peak ratio and smoothness index calculated by different methods in chlinical evaluation of long-gffective antihypertensive agents

The Efficacy of Nebivolol on Patient with Mild or Moderate Mssential Hypertension by Different Smbulatory Blood Pressure Monitoring Methods

The Effect of Three Different Cuff/Arm Circumference Ratios Ranging over 80% on Cuff Blood Pressure Measurements

OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION

PS-C31-2: PRELIMINARY STUDY OF ANTIHYPERTENSIVE TREATMENT EFFECT ON EARLY EVENING ELEVATED BLOOD PRESSURE

Evaluation of Indapamide Sustained-Released on Antihypertensive Effect Assessed by Ambulatory Blood Pressure Monitoring

Profile on Circadian Blood Pressure and the Influencing Factors in Essential Hypertensive Patients after Treatment

CAN A DAYTIME PROFILE OF HOME BLOOD PRESSURE MONITORING PREVENT HYPOTENSION DUE TO OVERDOSING OR INTERACTION WITH OTHER DRUGS?

Using Different Methods to Evaluate the Efficacy of Olmesartan Medoxomil in Chinese Patients with Mild to Moderate Essential Hypertension According to Ambulatory Blood Pressure Monitoring

A randomized controlled trial on home blood pressure monitoring and quality of care in stage 2 and 3 hypertension

S-56-2: HOME BLOOD PRESSURE MEASUREMENT FOR HYPERTENSION MANAGEMENT IN THE REAL WORLD: THE IMPORTANCE OF REPORTING HOME BLOOD PRESSURE TO DOCTORS

Ambulatory Blood Pressure Monitoring for the Management of Hypertension

Analysis of Ambulatory Blood Pressure Monitoring Data of Chronic Kidney Disease Patients with Refractory Hypertension

Ambulatory blood pressure using 60 rather than 20-min intervals may better reflect the resting blood pressure

Comparison of Optimal Diagnostic Thresholds of Hypertension With Home Blood Pressure Monitoring and 24-Hour Ambulatory Blood Pressure Monitoring

Comparison of blood pressure control standards based on home blood pressure monitoring and automated office blood pressure in patients with type 2 diabetes and hypertension in Shared Care Clinic

Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management

ANALYSIS OF DETECTION RATE OF EARLY EVENING ELEVATED BLOOD PRESSURE IN HYPERTENSIVE PATIENTS BY AMBULATORY BLOOD PRESSURE MONITORING